Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CDK
    (1)
  • COX
    (1)
  • IRAK
    (1)
  • PI3K
    (1)
  • Prostaglandin Receptor
    (1)
  • TNF
    (1)
  • p38 MAPK
    (1)
  • Others
    (1)
TargetMol | Tags By Natures
  • Saururus
    (1)
TargetMol | Tags By ResearchField
  • Immune System
    (1)
  • Inflammation
    (1)
  • Metabolism
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

T20728

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    5
    TargetMol | All_Pathways
  • Dye Reagents
    1
    TargetMol | All_Dye_Reagents
  • Natural Products
    1
    TargetMol | Natural_Products
  • Isotope Products
    1
    TargetMol | Isotope_Products
Licarin A
(-)-Licarin A
T2072851020-86-1
Licarin A is a natural anti-inflammatory lignan that inhibiting PKCα/βII and p38 MAPK pathways, thereby decreasing TNF-α and prostaglandin D2 (PGD2) secretion as well as COX-2 expression.
  • $84
In Stock
Size
QTY
1,3-Di-tert-butyl-5-iodobenzene-D3
T207281
1,3-Di-tert-butyl-5-iodobenzene-D3 is the deuterium-labeled variant of 1,3-Di-tert-butyl-5-iodobenzene.
  • Inquiry Price
Inquiry
Size
QTY
IRAK1/4/pan-FLT3 Kinase-IN-2
T2072862760329-44-8
IRAK1/4/pan-FLT3 Kinase-IN-2 (compound 27) is a potent dual inhibitor of IRAK1/4 and FLT3 with IC50 values of 10 nM, 0.7 nM, and < 0.5 nM, respectively. This compound enhances survival in mice models of acute myeloid leukemia.
  • Inquiry Price
10-14 weeks
Size
QTY
CDK2 degrader 6
T2072873036606-92-2
CDK2 degrader6 (compound 6) is an orally active CDK2 degrader with a DC50 of 46.5 nM, and is applicable in breast cancer research.
  • Inquiry Price
10-14 weeks
Size
QTY
(2S)-SB02024
T2072882126737-29-7
(2S)-SB02024 (SB02877) is the S-enantiomer of SB02024 and acts as a Vps34 inhibitor.
  • Inquiry Price
10-14 weeks
Size
QTY